TY - JOUR
T1 - Stereotactic ablative body radiation therapy for primary kidney cancer: a 3-dimensional conformal technique associated with low rates of early toxicity
AU - Pham, Daniel Josef
AU - Thompson, Ann
AU - Kron, Tomas
AU - Foroudi, Farshad
AU - Schneider, Michal E
AU - Devereux, Thomas
AU - Lim, Andrew
AU - Siva, Shankar
PY - 2014
Y1 - 2014
N2 - PURPOSE: To describe our 3-dimensional conformal planning approaches and report early toxicities with stereotactic body radiation therapy for the management of primary renal cell carcinoma. METHODS AND MATERIALS: This is an analysis of a phase 1 trial of stereotactic body radiation therapy for primary inoperable renal cell carcinoma. A dose of 42 Gy/3 fractions was prescribed to targets >/=5 cm, whereas for 100 cm(3) the median beam number used was 10 (4 noncoplanar) for an average R50 value of 4.3. The R50 was inversely proportional to decreasing PTV volume (r=-0.62, P=.003) and increasing total beams used (r=-0.51, P=.022). Twelve of 20 patients (60 ) suffered grade
AB - PURPOSE: To describe our 3-dimensional conformal planning approaches and report early toxicities with stereotactic body radiation therapy for the management of primary renal cell carcinoma. METHODS AND MATERIALS: This is an analysis of a phase 1 trial of stereotactic body radiation therapy for primary inoperable renal cell carcinoma. A dose of 42 Gy/3 fractions was prescribed to targets >/=5 cm, whereas for 100 cm(3) the median beam number used was 10 (4 noncoplanar) for an average R50 value of 4.3. The R50 was inversely proportional to decreasing PTV volume (r=-0.62, P=.003) and increasing total beams used (r=-0.51, P=.022). Twelve of 20 patients (60 ) suffered grade
UR - http://www.sciencedirect.com/science/article/pii/S036030161403555X
U2 - 10.1016/j.ijrobp.2014.07.043
DO - 10.1016/j.ijrobp.2014.07.043
M3 - Article
SN - 0360-3016
VL - 90
SP - 1061
EP - 1068
JO - International Journal of Radiation Oncology Biology Physics
JF - International Journal of Radiation Oncology Biology Physics
IS - 5
ER -